
Spexis AG bags money for pivotal Phase III trial
The cash injection of US$2.5m that was led by SPRIM Global Investments (SGI) is urgently needed to finance US commercialisation of the company’s...

Researchers stop brain cell death in Alzheimer’s mice
The research team led by Prof. Bart De Strooper (VIB-KU Leuven/UK Dementia Research Institute), and Dr Sriram Balusu (VIB-KU Leuven) has finally...

Smarter, faster, cheaper: Veeva shows how
Achieving the highest possible speed in innovation to meet patients’ unmet needs. That was the palpable goal all the pharmaceutical and life sciences...

New BIOTECH insight newsletter out
In its latest issue, the BIOTECH Insight newsletter of Deutsche Börse AG and its partner BIOCOM AG covers latest figures of a company survey that...

Aboleris Pharma bags €27.3m in Series A Financing
AbolerIS Pharma SA’s financing was led by Caixa Capital Risc and co-led by Sound Bioventures and existing investor Newton Biocapital with...

Study: New breeding methods hardly contribute to climate protection
Up and down the country, national governments and the EU Commission (EC) are campaigning to facilitate the commercialisation of cis-gentic and...

Enzyme foams morer active and stable
So far, foamed enzymes changed their structure and thus function. However, the new method, for which a patent has been filed circumvents this...